An interpretation of the expert consensus on standards for the management of patients with primary mitochondrial disease from the Mitochondrial Medicine Society.
- Author:
Yi GUO
1
;
Si-Qi HONG
;
Li JIANG
Author Information
1. Department of Neurology, Children's Hospital, Chongqing Medical University, Chongqing 400014, China. dr_jiangli@gmail.com.
- Publication Type:Journal Article
- MeSH:
Consensus;
Humans;
Mitochondrial Diseases;
Societies, Medical
- From:
Chinese Journal of Contemporary Pediatrics
2018;20(11):887-892
- CountryChina
- Language:Chinese
-
Abstract:
Primary mitochondrial disease is the most common inborn error of metabolism and is highly heterogeneous in terms of clinical manifestations and inheritance pattern. It has high mortality and disability rates. Multiple systems are often involved in this disease, and it is necessary to perform comprehensive evaluation and multidisciplinary management. The Mitochondrial Medicine Society issued the standard for the management of patients with primary mitochondrial disease: consensus statements from the Mitochondrial Medicine Society in 2017. The statements provided recommendations based on such consensus to guide the management and care of patients. This article interprets and summarizes the screening of organs and systems commonly involved in primary mitochondrial disease and the management of patients according to the consensus.
